Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-000689
Filing Date
2025-02-06
Accepted
2025-02-06 16:30:29
Documents
82
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tech-20241231x10q.htm   iXBRL 10-Q 2660774
2 EX-31.1 tech-20241231xex31d1.htm EX-31.1 9541
3 EX-31.2 tech-20241231xex31d2.htm EX-31.2 9531
4 EX-32.1 tech-20241231xex32d1.htm EX-32.1 5624
5 EX-32.2 tech-20241231xex32d2.htm EX-32.2 5650
  Complete submission text file 0001558370-25-000689.txt   12870524

Data Files

Seq Description Document Type Size
6 EX-101.SCH tech-20241231.xsd EX-101.SCH 52051
7 EX-101.CAL tech-20241231_cal.xml EX-101.CAL 80740
8 EX-101.DEF tech-20241231_def.xml EX-101.DEF 217133
9 EX-101.LAB tech-20241231_lab.xml EX-101.LAB 473577
10 EX-101.PRE tech-20241231_pre.xml EX-101.PRE 405898
85 EXTRACTED XBRL INSTANCE DOCUMENT tech-20241231x10q_htm.xml XML 3535906
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17272 | Film No.: 25597849
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)